Latest News about BMRN
Recent news which mentions BMRN
Why Biomarin Pharmaceutical Stock Hit A New 52-Week High Today
November 23, 2022
Tickers
BMRN
From Benzinga
$1.4 Million Bet On This Real Estate Stock? 3 Stocks Insiders Are Buying
November 03, 2022
From Benzinga
10 Analysts Have This to Say About Biomarin Pharmaceutical
October 31, 2022
Tickers
BMRN
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
October 31, 2022
From Benzinga
Mastercard To $428? Plus This Analyst Slashes PT On Intel
October 31, 2022
From Benzinga
BioMarin Lays Off 4% Of Its Workforce To 'Simplify' The Company
October 07, 2022
Tickers
BMRN
From Benzinga
Do Back-to-Back Approvals Make This Biotech Stock a Buy Now?
September 22, 2022
From Motley Fool
BioMarin Says One Participant Diagnosed With Leukemia In Late-Stage Hemophilia Gene Therapy Trial
September 12, 2022
Tickers
BMRN
From Benzinga
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
August 24, 2022
From Benzinga
BioMarin Receives European Commission's Conditional Marketing Authorization For Gene Therapy Candidate
August 24, 2022
Tickers
BMRN
From Benzinga
What's Next in Pfizer's M&A Ramp-Up?
August 20, 2022
From Motley Fool
Hopeful Golden Cross Forms On Biomarin Pharmaceutical's Chart
August 09, 2022
Tickers
BMRN
From Benzinga
From Benzinga
From MarketWatch
7 Undervalued Biotech Stocks to Buy Before They Boom
July 25, 2022
From InvestorPlace
From Benzinga
From Benzinga
From Motley Fool
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
